- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
IMMUNOLOGICAL RESPONSE TO HEPATITIS B VACCINE IN END STAGE RENAL DISEASES | ||
| IRAQI JOURNAL OF MEDICAL SCIENCES | ||
| Article 1, Volume 14, Issue 1, 2016, Pages 62-66 | ||
| Author | ||
| Jawad K. Manuti | ||
| Abstract | ||
| Background:End stage renal diseases patients have lower seroconversion rates compared with the subjects with intact renal function. Moreover, even after the completion of vaccination schedule anti-hepatitis B titers of responder who kept on dialysis, patients are low and decline logarithmically with time. Objectives:To determine the response of patients with end stage renal disease undergone hemodialysis to hepatitis B virus vaccination and to identify the factors that could affect this response. Methods:One hundred patients with an age range from 21 to 75 years complaining of chronic renal failure on regular hemodialysis. Patients negative for hepatitis B antigen and anti-hepatitis C were vaccinated with 40µg of Euvax B intramuscularly in the deltoid muscle by following a schedule of 0, 1 and 2 months. The antibody titer was tested at third month and if titer was <10 or 10-100IU/mL (patients whom regarded as non-responded or poor responded). Then they were given another fourth dose (40µg) of vaccine at sixth month. Results:The rate of seroconversion to hepatitis B vaccine among individuals with end stage renal disease is 63%. Thirty one (31%) patients were anti hepatitis C virus positive. Eighteen (58%) were responsive to hepatitis B vaccination and 13 (42%) did not response to Hepatitis B vaccination. Advanced age, sex and diabetes mellitus show no effect on response to vaccination. The response to hepatitis B vaccine is significant in patient's well control of hemoglbulin, calcium, albumin and long duration on hemodialysis. Conclusion:Patients on maintenance dialysis typically show a suboptimal immune response to hepatitis B virus vaccine compared with the non-uraemic population. Keyword: Hemodialysis, chronic renal failure, HBsAg, vaccination. | ||
| Keywords | ||
| hemodialysis; chronic renal failure; HBsAg; Vaccination | ||
|
Statistics Article View: 29 PDF Download: 2 |
||